These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16696473)

  • 61. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
    Crook J; McLean M; Yeung I; Williams T; Lockwood G
    Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of intraoperative edema during transperineal permanent prostate brachytherapy on computer-optimized and preimplant planning techniques.
    Yamada Y; Potters L; Zaider M; Cohen G; Venkatraman E; Zelefsky MJ
    Am J Clin Oncol; 2003 Oct; 26(5):e130-5. PubMed ID: 14528087
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion.
    Taussky D; Austen L; Toi A; Yeung I; Williams T; Pearson S; McLean M; Pond G; Crook J
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):974-80. PubMed ID: 15989997
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment planning consideration for prostate implants with the new linear RadioCoil 103Pd brachytherapy source.
    Meigooni AS; Awan SB; Rachabatthula V; Koona RA
    J Appl Clin Med Phys; 2005; 6(3):23-36. PubMed ID: 16143789
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Walbert HL
    Radiat Oncol Investig; 1998; 6(4):182-90. PubMed ID: 9727878
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In regard to Anagnostopoulos et al.: In vivo thermoluminescence dosimetry dose verification of transperinal (192)Ir high dose rate brachytherapy using CT-based planning for the treatment of prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:1183-1191).
    Duggan L; Bucci J; Kron T
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):911; author reply 911-2. PubMed ID: 15183495
    [No Abstract]   [Full Text] [Related]  

  • 67. Comparison between real-time intra-operative ultrasound-based dosimetry and CT-based dosimetry for prostate brachytherapy using cesium-131.
    Jacobs BL; Gibbons EP; Smith RP; Beriwal S; Komanduri K; Benoit RM
    Technol Cancer Res Treat; 2008 Dec; 7(6):463-9. PubMed ID: 19044326
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants.
    Moerland MA; van Deursen MJ; Elias SG; van Vulpen M; Jürgenliemk-Schulz IM; Battermann JJ
    Radiother Oncol; 2009 May; 91(2):202-6. PubMed ID: 18950884
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.
    Haworth A; Ebert M; St Clair S; Carey BM; Flynn A; Bottomley DM; Duchesne GM; Joseph D; Ash D
    Brachytherapy; 2005; 4(2):146-53. PubMed ID: 15893269
    [TBL] [Abstract][Full Text] [Related]  

  • 70. On the need to compensate for edema-induced dose reductions in preplanned (131)Cs prostate brachytherapy.
    Chen ZJ; Deng J; Roberts K; Nath R
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):303-10. PubMed ID: 17980500
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution.
    Rutten TP; Lawson JM; Marcu LG
    Phys Med; 2013 Nov; 29(6):662-9. PubMed ID: 22975428
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intraoperative dynamic dosimetry for prostate implants.
    Todor DA; Zaider M; Cohen GN; Worman MF; Zelefsky MJ
    Phys Med Biol; 2003 May; 48(9):1153-71. PubMed ID: 12765329
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of implant quality between intraoperatively built custom-linked seeds and loose seeds in permanent prostate brachytherapy using sector analysis.
    Katayama N; Takemoto M; Takamoto A; Ihara H; Katsui K; Ebara S; Nasu Y; Kanazawa S
    J Radiat Res; 2016 Jul; 57(4):393-9. PubMed ID: 26976125
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of post-implant dosimetry in the quality assessment of prostate implants. The RAH experience.
    Marcu L; Quach K
    Australas Phys Eng Sci Med; 2006 Dec; 29(4):310-4. PubMed ID: 17260585
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biologically effective dose for permanent prostate brachytherapy taking into account postimplant edema.
    Van Gellekom MP; Moerland MA; Kal HB; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):422-33. PubMed ID: 12023147
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comparison of postimplant dosimetry for (103)Pd versus (131)Cs seeds on a retrospective series of PBSI patients.
    Ravi A; Keller BM; Pignol JP
    Med Phys; 2011 Nov; 38(11):6046-52. PubMed ID: 22047369
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
    Dicker AP; Lin CC; Leeper DB; Waterman FM
    Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
    Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
    Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.